TD Cowen Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $53
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $84 to $53.
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $84 to $53.